Sapiens International Corporation N.V.
SPNS
$27.58
$0.311.14%
| Weiss Ratings | SPNS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | B | |||
| Rating Factors | SPNS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Good | |||
| Growth Index | Excellent | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | SPNS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.79 | |||
| Price History | SPNS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -1.39% | |||
| 30-Day Total Return | 3.76% | |||
| 60-Day Total Return | -3.16% | |||
| 90-Day Total Return | -25.22% | |||
| Year to Date Total Return | 5.71% | |||
| 1-Year Total Return | -6.83% | |||
| 2-Year Total Return | 46.57% | |||
| 3-Year Total Return | 19.34% | |||
| 5-Year Total Return | 101.04% | |||
| 52-Week High % Change | -33.84% | |||
| 52-Week Low % Change | 9.04% | |||
| Price | SPNS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $41.22 | |||
| 52-Week Low Price | $25.01 | |||
| 52-Week Low Price (Date) | Jan 10, 2025 | |||
| 52-Week High Price (Date) | Jul 23, 2024 | |||
| Valuation | SPNS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.52B | |||
| Enterprise Value | 1.37B | |||
| Price/Earnings (TTM) | 24.43 | |||
| Earnings Per Share (TTM) | 1.12 | |||
| Earnings Per Share Growth | 18.78% | |||
| Price/Earnings To Growth | 1.30 | |||
| Price/Sales (TTM) | 2.96 | |||
| Price/Book (Q) | 3.40 | |||
| Enterprise Value/Revenue (TTM) | 2.67 | |||
| Price | $27.58 | |||
| Enterprise Value/EBITDA (TTM) | 14.46 | |||
| Enterprise Value/EBIT | 17.32 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | SPNS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 55.91M | |||
| Dividend Yield | 2.09% | |||
| Div. Per Share (Most Recent) | $0.29 | |||
| Dividend Per Share (TTM) | $0.57 | |||
| Payout Ratio (TTM) | 45.07% | |||
| Dividend Per Share (Most Recent) | $0.29 | |||
| Company Info | SPNS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 972 3 790 2000 | |||
| Address | -- | |||
| Website | www.sapiens.com | |||
| Country | Israel | |||
| Year Founded | 1982 | |||
| Profitability | SPNS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 15.38% | |||
| Profit Margin | 12.13% | |||
| Management Effectiveness | SPNS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 7.29% | |||
| Return on Equity | 14.74% | |||
| Income Statement | SPNS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 514.58M | |||
| Total Revenue (TTM) | 514.58M | |||
| Revenue Per Share | $9.20 | |||
| Gross Profit (TTM) | 219.59M | |||
| EBITDA (TTM) | 94.86M | |||
| EBIT (TTM) | 79.19M | |||
| Net Income (TTM) | 62.44M | |||
| Net Income Avl. to Common (TTM) | 62.44M | |||
| Total Revenue Growth (Q YOY) | 9.54% | |||
| Earnings Growth (Q YOY) | 28.00% | |||
| EPS Diluted (TTM) | 1.12 | |||
| EPS Diluted Growth (Q YOY) | 25.01% | |||
| Balance Sheet | SPNS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 202.12M | |||
| Cash Per Share (Q) | $3.62 | |||
| Total Current Assets (Q) | 314.90M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 449.95M | |||
| Current Ratio (Q) | 2.112 | |||
| Book Value Per Share (Q) | $8.03 | |||
| Total Assets (Q) | 689.62M | |||
| Total Current Liabilities (Q) | 149.12M | |||
| Total Debt (Q) | 87.05M | |||
| Total Liabilities (Q) | 239.68M | |||
| Total Common Equity (Q) | 447.27M | |||
| Cash Flow | SPNS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -72.78M | |||
| Cash from Financing (TTM) | -43.34M | |||
| Net Change in Cash (TTM) | -33.57M | |||
| Levered Free Cash Flow (TTM) | 32.07M | |||
| Cash from Operations (TTM) | 79.43M | |||
